학술논문
Efficacy and tolerability of varenicline, an α 4β 2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
Document Type
Article
Author
Source
In Clinical Therapeutics 2007 29(6):1040-1056
Subject
Language
ISSN
0149-2918